Science & Medicine Group Announces Top Life Science Editors to Lead LabPulse and The Science Advisory Board

Experienced industry journalists will drive expanded editorial coverage and content opportunities across digital channels focused on diagnostics and life science innovation

ARLINGTON, Va., October 18, 2022 /PRNewswire/ — Science and Medicine Group Inc. (SMG), a data intelligence company that delivers actionable insights into hard-to-reach audiences in life sciences and healthcare, today announced the appointment of Leo O’Connor as editor-in-chief of LabPulseand Greg Slabodkin as editor-in-chief of The Scientific Advisory Board. With decades of industry experience, these editorial leads will help expand SMG’s two popular data and intelligence resources, known for providing insights into scientific advances, collaborations and trends in key market segments including life science research, clinical laboratories , Pharma and Biotech.

(PRNews photo/Science and Medicine Group)

(PRNews photo/Science and Medicine Group)

“SMG is driving our strategy to be the business intelligence and market research partner of choice for our healthcare and life sciences customers who seek highly curated digital channels to reach their target markets and grow their business.” said Sam OsmanCEO of the Science and Medicine Group.

“Leo and Greg bring extensive industry experience to SMG that will help us empower our clients with real-time news and actionable insights they can use to inform their product development and go-to-market strategies. On behalf of the entire team, we look forward to their contributions in supporting SMG as it continues to build its world-class editing and content creation capabilities across two of our key digital media, LabPulse and The Science Advisory Board,” said Barry LovetteGeneral Manager, Media at Science and Medicine Group.

Also Read :  Health ministry includes coronary stents in National List of Essential Medicines : The Tribune India

LabPulse is a leading online forum for pathologists, laboratory technicians, clinical researchers, managers, members of organized medicine and industry to connect and learn about clinical laboratory issues.

Before joining SMG, O’Connor was senior editor at GenomeWeb for six years, where he led editorial coverage for the 360Dx channel. Prior to that, he spent 15 years at Frost & Sullivan, most recently as Vice President of Research and Consulting. Earlier in his career, he also worked at Wiley Publishing as managing editor and acquisitions editor.

“I look forward to joining SMG as they embark on an exciting period of growth focused on building their reputation as the most trusted source of information for the clinical laboratory community,” said O’Connor. “I look forward to working with the team to tell stories that go deeper and address the critical issues and interests of a broader audience in clinical laboratories performing important work that ultimately impacts patient outcomes.”

Also Read :  462 medicine samples declared spurious during 2019-21

The Science Advisory Board is an international community of life science and medical professionals involved in biological research, drug discovery and biopharmaceutical production. Members share their knowledge and experience with the community, take advantage of opportunities to contribute to market research studies, and earn rewards for their involvement. The Science Advisory Board is also a channel for researchers, professionals, trainees, and advocates to keep up to date with news and trends in life sciences and biopharmaceuticals.

Slabodkin has over two decades of experience writing about medical technology for a variety of professional publications. Prior to joining SMG, he was Senior Editor of MedTech Dive, part of Industry Dive, and prior to that he served as Senior Editor of Health Data Management. Slabodkin received a Gold Award for Best Case Study from the American Society of Healthcare Publication Editors and is a Healthcare Fellow of the Society for Advancing Business Editing and Writing.

“The Science Advisory Board community is one of the most intellectually stimulating, diverse and compelling groups of professionals shaping the future of life sciences and drug discovery and development,” said Slabodkin. “I am very excited to lead SAB as it enters its next phase of growth, increasing its interactions and meaningful exchanges across multidisciplinary scientific fields.”

Also Read :  Eight Penn Medical School researchers win 'High-Risk, High-Reward' grants from the NIH

For more information on LabPulse, visit:

Further information on the Scientific Advisory Board can be found at:

About the Science and Medicine Group

Science and Medicine Group’s mission is to be the leading data intelligence company to deliver actionable insights into hard-to-reach scientific and medical audiences. The company is actively expanding its portfolio of data intelligence solutions, building on the long-standing success of its well-known market research brands such as Bioinformatics and Kalorama, its media sites such as and LabPulse, and The Science Advisory Board. a network of scientists engaged in biological research, drug discovery and biopharmaceutical production. The company’s breadth of data-driven offerings and value creation across its world-class brands drives customer product growth and commercialization efforts to create competitive advantages for its customers. The company is based in Arlington, Va. For more information visit

media contact
Anthony Petrucci
[email protected]



Watch original content to download multimedia:–medicine-group-announces-top-life-science-editors-to-lead-labpulse-and- the-science-advisory-board-301651210.html

SOURCE Science and Medicine Group Inc


Leave a Reply

Your email address will not be published.